How long does OATS knee recovery take?

Most patients find they can manage everyday tasks — walking, driving, light work — within 3–4 months of OATS or mosaicplasty surgery. Reaching that point, however, is only part of the journey. Full recovery typically spans 6–12 months, and clearance for competitive or high-impact sport can extend to 12–18 months depending on the demands of the activity and how the graft heals.

The reason the timeline is longer than many people expect is not simply wound healing. The transplanted bone-and-cartilage plugs must biologically integrate with the surrounding joint surface — a process called graft maturation — in which new blood vessels grow into the bone portion and the cartilage gradually bonds with adjacent tissue. This remodelling takes months, and loading the joint too early risks displacing or damaging the graft before it has secured itself.

It is worth noting that, on average, OATS and mosaicplasty patients take longer to return to sport than those who have had microfracture, even though the long-term durability of osteochondral grafts is substantially better.

Recovery broadly follows four phases: a protection phase (weeks 0–6), early rehabilitation (roughly weeks 2–12), progressive loading (months 3–6), and a return-to-activity phase (months 6–12 and beyond). Each phase is outlined below.

The first six weeks — protecting the graft

For the first six weeks, the overriding priority is protecting the graft while bone integration begins. Patients leave hospital on crutches, and weight-bearing is either strictly toe-touch or completely avoided — the exact restriction depends on lesion size and surgeon preference. Some protocols allow crutch weaning to begin at two to three weeks for smaller lesions; others maintain toe-touch restriction for the full six weeks, particularly where the defect involved a weight-bearing surface or required multiple plugs.

A hinged knee brace or immobiliser is typically worn during this period, though most surgeons allow it to come off at night after the first week. Prolonged standing and any distance walking are best avoided for the first seven to ten days, and long-distance travel should be delayed for at least two weeks.

Swelling is managed with regular icing, leg elevation, and prescribed pain relief. Some surgeons also arrange a continuous passive motion (CPM) machine for home use — a motorised device that slowly bends and straightens the knee to prevent stiffness without placing load through the graft. Evidence on the optimal duration of CPM use is limited, so its role varies across centres; it is an adjunct rather than a universal requirement.

Around day 14, stitches come out at the first formal post-operative review. The surgeon will typically check wound healing, assess swelling, confirm range of motion progress, and review whether the weight-bearing plan needs any adjustment before physiotherapy begins in earnest.

Early rehabilitation — building movement from weeks 6 to 12

Around the six-week mark, a surgeon review typically confirms whether bone integration has progressed well enough to clear full weight-bearing. Once it has, the hinged brace comes off for good, and the focus shifts from passive protection to active rebuilding.

Stationary cycling is usually the first cardiovascular exercise introduced — it keeps the knee moving through a controlled range while placing minimal compressive load through the graft. Gentle straight-leg raises and progressive range-of-motion work help recover muscle bulk lost during the protection phase without putting the repaired surface at risk. As tolerance improves, closed-chain exercises — such as mini-squats and step-downs — are added, alongside core stability drills that reduce compensatory loading on the knee.

One point worth emphasising: the absence of pain during this phase does not mean the graft is ready for more. Cartilage and bone integration continues well beyond the point at which discomfort settles, and pushing into running, jumping, pivoting, or deep lunging before the surgeon gives clearance risks premature graft failure. The grafted tissue simply cannot yet tolerate those forces, regardless of how the knee feels day-to-day.

Physiotherapy supervision is particularly important here. A physiotherapist experienced in cartilage repair can pace the progression correctly, catch early signs of overloading, and adapt the programme if swelling re-emerges after exercise — a common signal that activity levels need tempering.

Returning to activity — months 3 to 12 and beyond

By the three-month mark, most patients have regained enough strength and stability to resume normal daily activities — including driving, desk-based work, and light exercise — though the knee is still adapting and high-impact activity remains off limits.

Between months three and six, the programme typically broadens to include deep squats, swimming, resistance training, and cautious agility drills, paced according to how the knee responds. Physically demanding work — roles involving prolonged standing, lifting, or uneven ground — usually requires a longer absence than sedentary employment, though knee-specific return-to-work data is limited and individual circumstances vary considerably.

The milestone that surprises many patients is the jogging timeline. Light jogging is generally not trialled until around eight to ten months post-surgery — considerably later than the discomfort-free knee might suggest is reasonable. Full clearance for competitive or pivoting sport typically falls between six and twelve months, and for high-demand sport such as football, skiing, or martial arts, some protocols extend that window to twelve to eighteen months.

Critically, progression through these milestones is driven by functional criteria rather than calendar dates alone. Surgeons and physiotherapists commonly use limb symmetry testing — comparing quadriceps strength and hop performance between legs — before granting sport clearance. A knee that looks and feels recovered may still fall short of the strength threshold required for safe return. Advancing on time alone, without objective assessment, increases the risk of re-injury or graft overload at a stage when the repaired surface has come so far.

How durable is OATS — what the evidence says

The evidence behind OATS and mosaicplasty is more substantial than for many cartilage procedures, and it paints a realistic — rather than uniformly optimistic — picture.

At three-year follow-up, Gudas et al. found good outcomes in 86–90% of OATS patients, a figure broadly consistent with the approximately 90% success rate reported at the 8th World Congress of the International Cartilage Repair Society. These shorter-term results set reasonable expectations for the early years of recovery.

The more telling data comes from a longer perspective. A comparative study by Solheim et al. (2018, n=203) followed patients for up to 15 years and found that osteochondral autograft transfer had a significantly lower failure rate — 51% — than microfracture at 66% (P=0.01), with a mean time to failure of 8.4 years versus 4.0 years for microfracture. OAT survival exceeded 80% for the first seven years and remained above 60% at fifteen years. That 15-year figure is not a failure story; it is a durability benchmark that substantially outperforms the alternative.

One nuance specific to the mosaicplasty variant is worth understanding. Because mosaicplasty uses several smaller plugs rather than a single cylinder of bone and cartilage, small gaps form between plugs. These gaps may fill with fibrocartilage — a tougher, less specialised tissue — rather than the hyaline cartilage that normally lines the joint. For smaller, well-contained lesions, a single-plug OATS may produce a more uniform surface. Whether this distinction affects long-term outcomes in an individual case is something to raise directly with the treating surgeon.

Donor-site morbidity — discomfort at the harvest site on the outer edge of the knee — is a further consideration that the current evidence does not fully quantify, making it another topic for a pre-operative conversation.

Who is OATS suited to — and finding the right specialist

OATS is not a universal solution for knee cartilage damage — understanding who it suits, and who it does not, matters as much as knowing the recovery timeline.

The procedure is typically considered for younger patients, generally under 50, with a single focal defect measuring approximately 1–2 cm² — or up to around 4 cm² where a mosaicplasty arrangement of multiple plugs is used. Candidates have usually tried conservative measures first, such as physiotherapy, activity modification, and injection-based support, without lasting relief. A BMI below 40 and no more than mild osteoarthritis — Kellgren-Lawrence grade 2 or lower — are standard prerequisites; significant joint-wide degeneration places OATS outside its appropriate scope. Previous infections, tumours, or inflammatory arthritis of the knee are also contraindications.

This is not a binary pass or fail. Where defects are larger, or where the joint surface involvement is more extensive, alternative techniques such as matrix-induced ACI (MACI), first-generation ACI, or a fresh osteochondral allograft may be better suited. These procedures exist precisely because OATS has a ceiling on defect size and is most effective in a narrower clinical window.

Suitability is confirmed through clinical assessment, MRI imaging, and a review of prior treatment history — a conversation that benefits from a surgeon who specialises in cartilage restoration rather than general orthopaedics.